CD8 T-cell epitopes vaccine against SARS-CoV-2
Monday, November 2, 2020 4:20 PM to 4:40 PM · 20 min. (Africa/Abidjan)
World Immunotherapy Congress
Vaccines, neoantigens and oncolytics
Presentation
Information
- Selection of T-cell epitopes in stable SARS-CoV-2 genome and high homology with previous CoVs
- Preclinical vaccination elicits viral-specific Tissue-resident memory T cells
- Identification of immunodominant CD8 T cell epitopes in convalescent COVID-19 patients
Nicolas Poirier, Chief Scientific Officer, OSE ImmunoTherapeutics